1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. Summary
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
Delayed London Stock Exchange  -  11:35 2022-07-06 am EDT
1166.00 GBX   +3.19%
07:44aSMITH & NEPHEW : Timing of Smith+Nephew second quarter trading and first half 2022 results - Form 6-K
PU
07/01Smith+Nephew announces first robotic-assisted surgery using its LEGION? CONCELOC Cementless Total Knee System
AQ
06/30Smith & Nephew Says First Robotic-Assisted Surgery Performed Using Its Legion Conceloc Knee Implants
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/30/2022 07/01/2022 07/04/2022 07/05/2022 07/06/2022 Date
1148(c) 1145(c) 1139(c) 1130(c) 1166 Last
1 836 204 1 712 641 1 008 244 3 380 982 1 981 626 Volume
-0.95% -0.26% -0.52% -0.79% +3.19% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 5 330 M - -
Net income 2022 485 M - -
Net Debt 2022 2 081 M - -
P/E ratio 2022 24,7x
Yield 2022 2,54%
Sales 2023 5 584 M - -
Net income 2023 637 M - -
Net Debt 2023 1 889 M - -
P/E ratio 2023 18,5x
Yield 2023 2,77%
Capitalization 12 084 M 12 084 M -
EV / Sales 2022 2,66x
EV / Sales 2023 2,50x
Nbr of Employees 18 369
Free-Float 98,9%
More Financials
Company
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - orthopedic surgery (42.1%): primarily orthopedic implants (hips, knees and shoulders) ; - sports medicine, arthroscopy and cervicofacial surgery (29.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound... 
More about the company
Ratings of Smith & Nephew Plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about SMITH & NEPHEW PLC
07:44aSMITH & NEPHEW : Timing of Smith+Nephew second quarter trading and first half 2022 results..
PU
07/01Smith+Nephew announces first robotic-assisted surgery using its LEGION? CONCELOC Cement..
AQ
06/30Smith & Nephew Says First Robotic-Assisted Surgery Performed Using Its Legion Conceloc ..
MT
06/30SMITH & NEPHEW PLC : Monthly statement on outstanding equity shares and voting rights
CO
06/28SMITH & NEPHEW : +Nephew opens world-class manufacturing facility in Malaysia to support i..
PU
06/21SMITH & NEPHEW : Current Report by Foreign Issuer (Form 6-K)
PU
06/20Smith & Nephew plc Announces Executive Changes
CI
06/20SMITH & NEPHEW PLC : Nomination
CO
06/15Smith+Nephew shares new research that estimates 3.5 billion hours of nurse time could b..
AQ
06/10Smith+Nephew announces new UK R&D and manufacturing facility for Advanced Wound Managem..
AQ
06/09Smith+Nephew Announces New UK R&D and Manufacturing Facility for Advanced Wound Managem..
CI
06/09SMITH & NEPHEW PLC : Security operations
CO
06/08Smith+Nephew Announces First Total Hip Replacement Cases on its CORI Surgical System Us..
CI
06/08UK loses court challenge against EU order to recover millions in state aid
RE
06/01Smith & Nephew Sells Two Cell Therapy Assets to Healiva
MT
More news
News in other languages on SMITH & NEPHEW PLC
06/30Smith & Nephew déclare que la première chirurgie assistée par robot a été réalisée à l'..
06/20Smith & Nephew plc annonce des changements de direction
06/09Smith+Nephew annonce la création d'un nouveau centre de R&D et de fabrication au Royaum..
06/08Smith+Nephew annonce les premiers cas de prothèse totale de hanche sur son système chir..
06/08Reino Unido pierde recurso judicial contra orden de la UE de recuperar millones en ayud..
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 13,87 $
Average target price 18,06 $
Spread / Average Target 30,2%
EPS Revisions
Managers and Directors
Deepak S Nath Chief Executive Officer & Director
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Roberto Quarta Chairman
Vasant Padmanabhan President-Research & Development
Paul Connolly President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
SMITH & NEPHEW PLC-12.64%11 721
STRYKER CORPORATION-24.46%76 395
INSPIRE MEDICAL SYSTEMS, INC.-12.63%5 546
AXONICS, INC.7.57%2 836
DOUBLE MEDICAL TECHNOLOGY INC.-23.86%2 399
GLAUKOS CORPORATION6.57%2 240